Anna Balato Selected Research

befunolol (Bentos)

1/2007

Allergic contact dermatitis due to levobunolol with cross-sensitivity to befunolol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Balato Research Topics

Disease

64	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2024 - 01/2008
8	Atopic Dermatitis (Atopic Eczema) 01/2024 - 03/2014
6	Allergic Contact Dermatitis 05/2024 - 01/2007
6	Hypersensitivity (Allergy) 03/2021 - 03/2008
6	Psoriatic Arthritis 01/2021 - 07/2017
5	Infections 01/2023 - 01/2008
5	Contact Dermatitis (Eczema, Contact) 01/2022 - 01/2011
5	Skin Diseases (Skin Disease) 01/2021 - 03/2014
5	Inflammation (Inflammations) 11/2019 - 11/2012
3	Obesity 04/2024 - 01/2016
3	Acne Vulgaris 01/2024 - 02/2016
2	Hidradenitis Suppurativa 02/2019 - 10/2017
2	Neoplasms (Cancer) 08/2009 - 07/2009
1	Body Weight (Weight, Body) 12/2024
1	Alopecia Areata 12/2023
1	Chronic Urticaria 11/2023
1	Lichen Planus (Lichen Ruber Planus) 01/2023
1	Lichen Sclerosus et Atrophicus (Lichen Sclerosus) 01/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2022
1	COVID-19 01/2022
1	Pruritus (Itching) 02/2020
1	Skin Manifestations 01/2020
1	Demyelinating Diseases (Demyelinating Disease) 08/2018
1	Nervous System Diseases (Neurological Disorders) 08/2018
1	Multiple Sclerosis 08/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Vascular Diseases (Vascular Disease) 01/2018
1	Atherosclerosis 01/2018
1	Dermatitis 12/2017
1	Necrosis 07/2017
1	Melanoma (Melanoma, Malignant) 04/2017
1	Insulin Resistance 12/2016

Drug/Important Bio-Agent (IBA)

9	InterleukinsIBA 04/2024 - 04/2015
9	Interleukin-17 (Interleukin 17)IBA 04/2024 - 12/2016
9	secukinumabIBA 12/2023 - 11/2017
6	CytokinesIBA 01/2021 - 12/2013
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2018 - 03/2011
5	Interleukin-23 (Interleukin 23)IBA 12/2024 - 01/2018
5	ixekizumabIBA 05/2024 - 11/2017
5	Irritants (Vesicants)IBA 05/2024 - 01/2011
5	Monoclonal AntibodiesIBA 12/2023 - 01/2018
4	upadacitinibIBA 01/2024 - 09/2022
4	Interleukin-12 (IL 12)IBA 01/2023 - 01/2018
4	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2012
4	Etanercept (Enbrel)FDA Link 02/2019 - 03/2011
3	Ustekinumab (CNTO 1275)FDA Link 04/2024 - 07/2017
3	Adalimumab (Humira)FDA Link 01/2023 - 02/2014
3	Interleukin-1 (Interleukin 1)IBA 12/2017 - 04/2013
3	Interleukin-33IBA 01/2017 - 11/2012
3	efalizumab (Raptiva)FDA Link 02/2014 - 01/2008
3	AllergensIBA 01/2011 - 07/2008
2	tildrakizumabIBA 12/2024 - 10/2023
2	guselkumabIBA 04/2024 - 01/2018
2	bimekizumabIBA 04/2024 - 01/2023
2	dupilumabIBA 01/2024 - 01/2023
2	Janus Kinase InhibitorsIBA 01/2024 - 11/2023
2	brodalumabIBA 01/2023 - 11/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2022 - 03/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2019 - 06/2014
2	Glycoproteins (Glycoprotein)IBA 01/2012 - 07/2009
2	Infliximab (Remicade)FDA Link 03/2011 - 04/2009
1	risankizumabIBA 01/2024
1	Omalizumab (Xolair)FDA Link 11/2023
1	Janus KinasesIBA 11/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2023
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 11/2022
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2021
1	AcidsIBA 02/2020
1	stearyl glycyrrhetinateIBA 02/2020
1	SaltsIBA 02/2020
1	Pyrrolidinones (Pyrrolidones)IBA 02/2020
1	cathepsin SIBA 02/2020
1	Carboxy-LyasesIBA 02/2020
1	Histidine (L-Histidine)FDA Link 02/2020
1	piroctone olamineIBA 02/2020
1	ZincIBA 02/2020
1	apremilastIBA 01/2020
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 11/2019
1	ElementsIBA 11/2019
1	Melanins (Melanin)IBA 11/2019
1	Aryldialkylphosphatase (Paraoxonase)IBA 04/2019
1	AntioxidantsIBA 04/2019
1	EnzymesIBA 04/2019
1	Lipoproteins (Lipoprotein)IBA 04/2019
1	Coffee FDA Link 01/2018
1	Interleukin-8 (Interleukin 8)IBA 10/2017
1	Antirheumatic Agents (DMARD)IBA 07/2017
1	Interferon-gamma (Interferon, gamma)IBA 04/2017
1	Interleukin-6 (Interleukin 6)IBA 04/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 12/2016
1	LeptinIBA 12/2016

Therapy/Procedure

18	Therapeutics 01/2023 - 03/2011
8	Biological Therapy 05/2024 - 01/2008
2	Phototherapy (Light Therapy) 08/2022 - 12/2020
1	Skin Care 01/2022
1	Personal Protective Equipment 01/2022
1	Polypharmacy 04/2020
1	Duration of Therapy 01/2019